No turnover in lens lipids for the entire human lifespan

  1. Jessica R Hughes  Is a corresponding author
  2. Vladimir A Levchenko
  3. Stephen J Blanksby
  4. Todd W Mitchell
  5. Alan Williams
  6. Roger J W Truscott
  1. University of Wollongong, Australia
  2. The Australian Nuclear Science and Technology Organisation, Australia
  3. Queensland University of Technology, Australia

Abstract

Lipids are critical to cellular function and it is generally accepted that lipid turnover is rapid and dysregulation in turnover results in disease (Dawidowicz 1987, Phillips et al. 2009, Liu et al. 2013). Here we present an intriguing counter-example by demonstrating that in the center of the human ocular lens there is no lipid turnover in fiber cells during the entire human lifespan. This discovery, combined with prior demonstration of pronounced changes in the lens lipid composition over a lifetime (Hughes et al. 2012), suggests that some lipid classes break down in the body over several decades, whereas others are stable. Such substantial changes in lens cell membranes may play a role in the genesis of age-related eye disorders. Whether long-lived lipids are present in other tissues is not yet known, but this may prove to be important in understanding the development of age-related diseases.

Article and author information

Author details

  1. Jessica R Hughes

    School of Medicine, University of Wollongong, Wollongong, Australia
    For correspondence
    jnealon@uow.edu.au
    Competing interests
    The authors declare that no competing interests exist.
  2. Vladimir A Levchenko

    The Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Stephen J Blanksby

    Central Analytical Research Facility, Queensland University of Technology, Brisbane, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Todd W Mitchell

    School of Medicine, University of Wollongong, Wollongong, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Alan Williams

    The Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Roger J W Truscott

    Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, Australia
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Human subjects: All work was approved by the human research ethics committees at the University of Sydney (#7292) and the University of Wollongong (HE 99/001). All human lenses from this study were donated to the Sydney Eye Bank.

Copyright

© 2015, Hughes et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,507
    views
  • 354
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jessica R Hughes
  2. Vladimir A Levchenko
  3. Stephen J Blanksby
  4. Todd W Mitchell
  5. Alan Williams
  6. Roger J W Truscott
(2015)
No turnover in lens lipids for the entire human lifespan
eLife 4:e06003.
https://doi.org/10.7554/eLife.06003

Share this article

https://doi.org/10.7554/eLife.06003

Further reading

    1. Cell Biology
    Chengfang Pan, Ying Liu ... Changlong Hu
    Research Article

    Prostaglandin E2 (PGE2) is an endogenous inhibitor of glucose-stimulated insulin secretion (GSIS) and plays an important role in pancreatic β-cell dysfunction in type 2 diabetes mellitus (T2DM). This study aimed to explore the underlying mechanism by which PGE2 inhibits GSIS. Our results showed that PGE2 inhibited Kv2.2 channels via increasing PKA activity in HEK293T cells overexpressed with Kv2.2 channels. Point mutation analysis demonstrated that S448 residue was responsible for the PKA-dependent modulation of Kv2.2. Furthermore, the inhibitory effect of PGE2 on Kv2.2 was blocked by EP2/4 receptor antagonists, while mimicked by EP2/4 receptor agonists. The immune fluorescence results showed that EP1–4 receptors are expressed in both mouse and human β-cells. In INS-1(832/13) β-cells, PGE2 inhibited voltage-gated potassium currents and electrical activity through EP2/4 receptors and Kv2.2 channels. Knockdown of Kcnb2 reduced the action potential firing frequency and alleviated the inhibition of PGE2 on GSIS in INS-1(832/13) β-cells. PGE2 impaired glucose tolerance in wild-type mice but did not alter glucose tolerance in Kcnb2 knockout mice. Knockout of Kcnb2 reduced electrical activity, GSIS and abrogated the inhibition of PGE2 on GSIS in mouse islets. In conclusion, we have demonstrated that PGE2 inhibits GSIS in pancreatic β-cells through the EP2/4-Kv2.2 signaling pathway. The findings highlight the significant role of Kv2.2 channels in the regulation of β-cell repetitive firing and insulin secretion, and contribute to the understanding of the molecular basis of β-cell dysfunction in diabetes.